\
&
Contact us
\
&
Contact us
Published on | 10 months ago
Programmes Horizon Europe HorizonEU L+F Horizon 2020The European Court of Auditors (ECA) audits the revenue and expenditure of the EU budget and delivers its opinion on the extent to which the annual accounts are reliable, and income and spending comply with the rules and regulations. This year it includes findings from Horizon 2020 audits but also from some Horizon Europe audits.
In chapter 5 (Single market, innovation and digital) the report contains the findings of ECA regarding personnel cost in research expenditure, and elaborates a.o. issues on daily rate calculations of Horizon Europe projects. ECA formulates already some recommendations towards daily rate, as eg. demanding by mid 2025 measures to enhance beneficiaries' compliance with the daily rate rules, clarification of the rules and methods for calculating the daily rate. In annexes of chapter 5 ECA recommends that experts should be required to document their assessment of the personnel cost calculation by end of 2024. The last chapter contains the replies of the European Commission, regarding Horizon 2020 and Horizon Europe from p. 441 onwards.
While Digital Europe as a quite new programme does not yet figure in this year’s report, the findings made for Horizon Europe can also be useful for Digital Europe applicants to consider when preparing their proposal and managing their projects.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Climate, Energy, Mobility Agro-Food, Environment EIT
The EIT (European Institute of Innovation and Technology) wants the three corners of the knowledge triangle to join forces to create succesful businesses. They consist of ten knowledge and innovation communities (KIC) each focussing on a specific sector. The KIC on Climate previously launched the 'Green Horizons farmers network', which foste... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
